biote Statistics
Total Valuation
biote has a market cap or net worth of $206.89 million. The enterprise value is $274.58 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 49.03 million shares outstanding. The number of shares has increased by 16.30% in one year.
| Current Share Class | 31.49M |
| Shares Outstanding | 49.03M |
| Shares Change (YoY) | +16.30% |
| Shares Change (QoQ) | -0.90% |
| Owned by Insiders (%) | 28.97% |
| Owned by Institutions (%) | 47.53% |
| Float | 15.38M |
Valuation Ratios
The trailing PE ratio is 7.03 and the forward PE ratio is 10.73.
| PE Ratio | 7.03 |
| Forward PE | 10.73 |
| PS Ratio | 0.71 |
| Forward PS | 0.97 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.59 |
| P/OCF Ratio | 4.67 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of 7.42.
| EV / Earnings | 13.05 |
| EV / Sales | 1.38 |
| EV / EBITDA | 7.16 |
| EV / EBIT | 7.43 |
| EV / FCF | 7.42 |
Financial Position
The company has a current ratio of 1.42
| Current Ratio | 1.42 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.80 |
| Debt / FCF | 2.96 |
| Interest Coverage | 3.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 16.29% |
| Return on Invested Capital (ROIC) | 49.39% |
| Return on Capital Employed (ROCE) | 49.32% |
| Revenue Per Employee | $918,797 |
| Profits Per Employee | $96,940 |
| Employee Count | 217 |
| Asset Turnover | 1.41 |
| Inventory Turnover | 2.88 |
Taxes
In the past 12 months, biote has paid $184,000 in taxes.
| Income Tax | 184,000 |
| Effective Tax Rate | 0.84% |
Stock Price Statistics
The stock price has decreased by -44.84% in the last 52 weeks. The beta is 1.21, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -44.84% |
| 50-Day Moving Average | 3.80 |
| 200-Day Moving Average | 4.82 |
| Relative Strength Index (RSI) | 58.94 |
| Average Volume (20 Days) | 141,178 |
Short Selling Information
The latest short interest is 860,450, so 1.76% of the outstanding shares have been sold short.
| Short Interest | 860,450 |
| Short Previous Month | 783,119 |
| Short % of Shares Out | 1.76% |
| Short % of Float | 5.59% |
| Short Ratio (days to cover) | 6.63 |
Income Statement
In the last 12 months, biote had revenue of $199.38 million and earned $21.04 million in profits. Earnings per share was $0.60.
| Revenue | 199.38M |
| Gross Profit | 142.09M |
| Operating Income | 36.95M |
| Pretax Income | 10.67M |
| Net Income | 21.04M |
| EBITDA | 38.33M |
| EBIT | 36.95M |
| Earnings Per Share (EPS) | $0.60 |
Full Income StatementBalance Sheet
The company has $41.70 million in cash and $109.38 million in debt, giving a net cash position of -$67.68 million or -$1.38 per share.
| Cash & Cash Equivalents | 41.70M |
| Total Debt | 109.38M |
| Net Cash | -67.68M |
| Net Cash Per Share | -$1.38 |
| Equity (Book Value) | -84.83M |
| Book Value Per Share | -2.86 |
| Working Capital | 20.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $44.34 million and capital expenditures -$7.36 million, giving a free cash flow of $36.98 million.
| Operating Cash Flow | 44.34M |
| Capital Expenditures | -7.36M |
| Free Cash Flow | 36.98M |
| FCF Per Share | $0.75 |
Full Cash Flow StatementMargins
Gross margin is 71.27%, with operating and profit margins of 18.53% and 10.55%.
| Gross Margin | 71.27% |
| Operating Margin | 18.53% |
| Pretax Margin | 10.93% |
| Profit Margin | 10.55% |
| EBITDA Margin | 19.22% |
| EBIT Margin | 18.53% |
| FCF Margin | 18.55% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.30% |
| Shareholder Yield | -16.30% |
| Earnings Yield | 10.17% |
| FCF Yield | 17.88% |
Analyst Forecast
The average price target for biote is $8.00, which is 89.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 89.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 10.47% |
| EPS Growth Forecast (5Y) | 78.08% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.36 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.36 |
| Piotroski F-Score | 7 |
